Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction

To investigate prospectively the feasibility of using optical tomography with ultrasonographic (US) localization to differentiate malignant from benign breast masses and to compare optical tomography with color Doppler US. The study was approved by the local internal review board committee and by th...

Full description

Saved in:
Bibliographic Details
Published inRadiology Vol. 237; no. 1; p. 57
Main Authors Zhu, Quing, Cronin, Edward B, Currier, Allen A, Vine, Hugh S, Huang, Minming, Chen, NanGuang, Xu, Chen
Format Journal Article
LanguageEnglish
Published United States 01.10.2005
Subjects
Online AccessGet more information

Cover

Loading…
Abstract To investigate prospectively the feasibility of using optical tomography with ultrasonographic (US) localization to differentiate malignant from benign breast masses and to compare optical tomography with color Doppler US. The study was approved by the local internal review board committee and by the Human Subjects Research Review Board of Army Medical Research and Materiel Command. Signed informed consent was obtained, and the study was HIPAA compliant. Between May 2003 and March 2004, 65 consecutive women (mean age, 51 years; age range, 24-80 years) with 81 breast lesions underwent US-guided biopsy and were scanned with a combined imager. The hand-held probe, which consisted of a centrally located US transducer surrounded by near-infrared sensors, was used to simultaneously acquire coregistered US images and optical data. The lesion location obtained at US was used to guide optical imaging reconstruction. Light absorption was measured at two wavelengths. From these measurements, tumor angiogenesis was assessed on the basis of calculated total hemoglobin concentration. A Student t distribution was used to calculate the statistical significance of mean maximum and mean average hemoglobin concentrations obtained in malignant and benign lesion groups, and P < .001 was considered to indicate a statistically significant difference. Biopsy results revealed eight early stage invasive carcinomas (malignant group) and 73 benign lesions (benign group). The mean maximum and mean average hemoglobin concentrations in the malignant group were 122 micromol/L +/- 26.8 (+/- standard deviation) and 88 micromol/L +/- 24.5, respectively. The mean maximum and mean average hemoglobin concentrations in the benign group were 55 micromol/L +/- 24.8 and 38 micromol/L +/- 17.4, respectively. Both the maximum and average total hemoglobin concentrations were significantly higher in the malignant group compared with the benign group (P < .001). When a maximum hemoglobin concentration of 95 micromol/L was used as the threshold value, the sensitivity, specificity, positive predictive value, and negative predictive value of optical tomography were 100%, 96%, 73%, and 100%, respectively, and the sensitivity, specificity, positive predictive value, and negative predictive value of color Doppler US were 63%, 69%, 19%, and 94%, respectively. Findings indicate that optical tomography with US localization is feasible for differentiating benign and early stage malignant breast lesions.
AbstractList To investigate prospectively the feasibility of using optical tomography with ultrasonographic (US) localization to differentiate malignant from benign breast masses and to compare optical tomography with color Doppler US. The study was approved by the local internal review board committee and by the Human Subjects Research Review Board of Army Medical Research and Materiel Command. Signed informed consent was obtained, and the study was HIPAA compliant. Between May 2003 and March 2004, 65 consecutive women (mean age, 51 years; age range, 24-80 years) with 81 breast lesions underwent US-guided biopsy and were scanned with a combined imager. The hand-held probe, which consisted of a centrally located US transducer surrounded by near-infrared sensors, was used to simultaneously acquire coregistered US images and optical data. The lesion location obtained at US was used to guide optical imaging reconstruction. Light absorption was measured at two wavelengths. From these measurements, tumor angiogenesis was assessed on the basis of calculated total hemoglobin concentration. A Student t distribution was used to calculate the statistical significance of mean maximum and mean average hemoglobin concentrations obtained in malignant and benign lesion groups, and P < .001 was considered to indicate a statistically significant difference. Biopsy results revealed eight early stage invasive carcinomas (malignant group) and 73 benign lesions (benign group). The mean maximum and mean average hemoglobin concentrations in the malignant group were 122 micromol/L +/- 26.8 (+/- standard deviation) and 88 micromol/L +/- 24.5, respectively. The mean maximum and mean average hemoglobin concentrations in the benign group were 55 micromol/L +/- 24.8 and 38 micromol/L +/- 17.4, respectively. Both the maximum and average total hemoglobin concentrations were significantly higher in the malignant group compared with the benign group (P < .001). When a maximum hemoglobin concentration of 95 micromol/L was used as the threshold value, the sensitivity, specificity, positive predictive value, and negative predictive value of optical tomography were 100%, 96%, 73%, and 100%, respectively, and the sensitivity, specificity, positive predictive value, and negative predictive value of color Doppler US were 63%, 69%, 19%, and 94%, respectively. Findings indicate that optical tomography with US localization is feasible for differentiating benign and early stage malignant breast lesions.
Author Cronin, Edward B
Zhu, Quing
Currier, Allen A
Xu, Chen
Chen, NanGuang
Huang, Minming
Vine, Hugh S
Author_xml – sequence: 1
  givenname: Quing
  surname: Zhu
  fullname: Zhu, Quing
  email: zhu@engr.uconn.edu
  organization: Bioengineering Program, Electrical and Computer Engineering Department, University of Connecticut, 371 Fairfield Rd, U2157, Storrs, CT 06269-1157, USA. zhu@engr.uconn.edu
– sequence: 2
  givenname: Edward B
  surname: Cronin
  fullname: Cronin, Edward B
– sequence: 3
  givenname: Allen A
  surname: Currier
  fullname: Currier, Allen A
– sequence: 4
  givenname: Hugh S
  surname: Vine
  fullname: Vine, Hugh S
– sequence: 5
  givenname: Minming
  surname: Huang
  fullname: Huang, Minming
– sequence: 6
  givenname: NanGuang
  surname: Chen
  fullname: Chen, NanGuang
– sequence: 7
  givenname: Chen
  surname: Xu
  fullname: Xu, Chen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16183924$$D View this record in MEDLINE/PubMed
BookMark eNo9T8lOxDAUy2EQs8AHcEH5gUK2LuEGIzZpJA4w59FL8lqCOukoSUH8PUUsvli2LMteklkYAhJyxtkF56q5jOD80F8IWXOmuJDVjCwYk7JoFNdzskzpjTGuyqY-JnNe8UZqoRakv8Hgu0DfMaYx0T30k4KQqYkIKU9GSpiu6HDI3kJPnW9bjBiyh-yHQD98fqXb56IbvUP3H_N76HzoaEQ7hJTjaL_TJ-SohT7h6S-vyPbu9mX9UGye7h_X15vCTvtyoSqspbXciQkWjYbSlWVtmCkNas0dd42FVgktyxorYTVUjIFRCtCo2ooVOf_pPYxmj253iNOe-Ln7uy2-ADSaXis
CitedBy_id crossref_primary_10_1007_s00330_009_1551_y
crossref_primary_10_1117_1_3499419
crossref_primary_10_7863_ultra_16_03063
crossref_primary_10_1016_j_clbc_2024_01_006
crossref_primary_10_1148_radiol_2016151097
crossref_primary_10_1007_s00330_008_1268_3
crossref_primary_10_1364_BOE_388816
crossref_primary_10_1364_OE_16_017505
crossref_primary_10_2214_AJR_22_28470
crossref_primary_10_1097_MD_0000000000001502
crossref_primary_10_1093_jbi_wbad057
crossref_primary_10_1118_1_4942813
crossref_primary_10_1073_pnas_0611058104
crossref_primary_10_1002_jbio_201200123
crossref_primary_10_1364_BOE_3_002078
crossref_primary_10_1117_1_2966703
crossref_primary_10_1016_S0098_1672_08_70310_2
crossref_primary_10_1364_BOE_5_003684
crossref_primary_10_1016_j_ejrad_2021_110029
crossref_primary_10_1117_1_JBO_17_8_080901
crossref_primary_10_1109_JSTQE_2009_2037723
crossref_primary_10_1007_s10555_008_9143_x
crossref_primary_10_1148_radiol_2432060286
crossref_primary_10_1118_1_2992048
crossref_primary_10_1016_j_jqsrt_2008_06_007
crossref_primary_10_1117_1_3431086
crossref_primary_10_1117_1_JBO_21_11_116007
crossref_primary_10_1038_s41467_018_04576_z
crossref_primary_10_1148_radiol_10091237
crossref_primary_10_1593_tlo_09157
crossref_primary_10_1142_S1793545809000620
crossref_primary_10_2214_AJR_10_5102
crossref_primary_10_1007_s10549_007_9582_z
crossref_primary_10_1016_j_urology_2010_06_017
crossref_primary_10_1117_1_JBO_28_8_086002
crossref_primary_10_1186_s13058_015_0578_z
crossref_primary_10_1038_nm_3732
crossref_primary_10_1117_1_JBO_21_7_074001
crossref_primary_10_1117_1_JBO_22_9_096011
crossref_primary_10_1364_AO_46_001597
crossref_primary_10_2214_AJR_17_18435
crossref_primary_10_1016_j_tranon_2017_10_011
crossref_primary_10_15171_jlms_2018_11
crossref_primary_10_1109_TBME_2012_2187900
crossref_primary_10_1016_j_jvir_2009_04_021
crossref_primary_10_1117_1_3505015
crossref_primary_10_1016_j_optlaseng_2024_108075
crossref_primary_10_1016_j_pacs_2024_100606
crossref_primary_10_1016_j_soc_2007_03_008
crossref_primary_10_3788_CJL231455
crossref_primary_10_1117_1_3306704
crossref_primary_10_1117_1_JBO_20_6_066002
crossref_primary_10_1364_BOE_428107
crossref_primary_10_1007_s10549_021_06320_6
crossref_primary_10_1117_1_3449570
crossref_primary_10_1016_j_jvir_2015_12_752
crossref_primary_10_1109_ICJECE_2023_3259239
crossref_primary_10_1016_j_tranon_2018_04_009
crossref_primary_10_1016_j_ejrad_2020_109067
crossref_primary_10_1007_s00330_014_3356_x
crossref_primary_10_1117_1_3600773
crossref_primary_10_1148_radiol_2018161041
crossref_primary_10_1364_OE_18_015917
crossref_primary_10_1186_s12880_020_00506_y
crossref_primary_10_1053_j_sult_2011_03_003
crossref_primary_10_1177_153303460600500408
crossref_primary_10_1088_0022_3727_40_18_034
crossref_primary_10_1148_radiol_09082134
crossref_primary_10_1002_ijc_22995
crossref_primary_10_1158_1078_0432_CCR_10_3213
crossref_primary_10_1109_JSTQE_2011_2177963
crossref_primary_10_1177_0161734615580280
crossref_primary_10_1016_j_enconman_2007_12_034
crossref_primary_10_1364_BOE_2_003267
crossref_primary_10_2147_CMAR_S331665
crossref_primary_10_1364_BOE_10_002528
crossref_primary_10_1117_1_JBO_24_5_056005
crossref_primary_10_1148_radiol_12120086
crossref_primary_10_1117_1_3569088
crossref_primary_10_1364_AO_45_005027
crossref_primary_10_1016_j_acra_2024_10_018
crossref_primary_10_1109_TITB_2009_2015144
crossref_primary_10_1364_BOE_8_005437
crossref_primary_10_1016_j_ultrasmedbio_2013_09_008
crossref_primary_10_1109_JSTQE_2011_2170664
crossref_primary_10_1371_journal_pone_0099683
crossref_primary_10_1007_s11307_008_0176_x
crossref_primary_10_1063_1_3271019
crossref_primary_10_1148_radiol_2403051630
crossref_primary_10_1088_2057_1976_aa87bb
crossref_primary_10_21294_1814_4861_2019_18_4_92_101
crossref_primary_10_1117_1_3160548
crossref_primary_10_1117_1_3573814
crossref_primary_10_1016_j_medengphy_2008_10_004
crossref_primary_10_1007_s10278_017_9958_5
crossref_primary_10_1007_s00330_011_2060_3
crossref_primary_10_1371_journal_pone_0147851
crossref_primary_10_1007_s11307_009_0269_1
crossref_primary_10_1016_j_ejrad_2012_01_029
crossref_primary_10_1148_radiol_2017172228
crossref_primary_10_1364_AO_54_008808
crossref_primary_10_1117_1_BIOS_2_1_012502
crossref_primary_10_1155_2012_863747
crossref_primary_10_1016_j_ultrasmedbio_2012_09_014
crossref_primary_10_1016_j_jvir_2007_08_027
crossref_primary_10_1364_OE_16_012190
crossref_primary_10_1364_OE_16_017484
crossref_primary_10_1117_1_3652711
crossref_primary_10_1593_neo_08602
crossref_primary_10_1364_BOE_416561
crossref_primary_10_1088_0031_9155_53_15_013
crossref_primary_10_1148_radiol_12112415
crossref_primary_10_1016_j_jqsrt_2018_09_032
crossref_primary_10_1186_s43094_020_00113_2
crossref_primary_10_1117_1_2956662
crossref_primary_10_1117_1_JBO_27_8_086003
crossref_primary_10_7863_ultra_34_5_749
crossref_primary_10_1016_j_acra_2014_12_012
crossref_primary_10_1118_1_4728228
crossref_primary_10_1016_j_acra_2008_01_028
crossref_primary_10_1016_j_clinimag_2012_05_003
crossref_primary_10_1118_1_3456926
crossref_primary_10_1016_j_ultrasmedbio_2011_03_010
ContentType Journal Article
Copyright RSNA, 2005
Copyright_xml – notice: RSNA, 2005
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1148/radiol.2371041236
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 16183924
Genre Journal Article
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA094044
– fundername: NIBIB NIH HHS
  grantid: R01 EB002136
GroupedDBID ---
.55
.GJ
123
18M
1CY
1KJ
29P
2WC
34G
39C
4.4
53G
5RE
6NX
6PF
7FM
AAEJM
AAQQT
AAWTL
ABDPE
ABHFT
ABOCM
ACFQH
ACGFO
ACJAN
ACRZS
ADBBV
AENEX
AENYM
AFFNX
AFOSN
AJJEV
AJWWR
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
F9R
GX1
H13
J5H
KO8
L7B
LMP
LSO
MJL
MV1
N4W
NPM
OK1
P2P
R.V
RKKAF
RXW
SJN
TAE
TR2
TRS
TWZ
VXZ
W8F
WH7
WOQ
X7M
YQI
YQJ
ZGI
ZKG
ZVN
ZXP
ID FETCH-LOGICAL-c458t-46e73cc1d2222ceb9a5d557b0b5be991d1d8caf429357e62c9a600ab44aeb47c2
ISSN 0033-8419
IngestDate Wed Feb 19 01:43:17 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License RSNA, 2005
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c458t-46e73cc1d2222ceb9a5d557b0b5be991d1d8caf429357e62c9a600ab44aeb47c2
OpenAccessLink http://doi.org/10.1148/radiol.2371041236
PMID 16183924
ParticipantIDs pubmed_primary_16183924
PublicationCentury 2000
PublicationDate 2005-10-01
PublicationDateYYYYMMDD 2005-10-01
PublicationDate_xml – month: 10
  year: 2005
  text: 2005-10-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Radiology
PublicationTitleAlternate Radiology
PublicationYear 2005
References 11937594 - J Nucl Med. 2002 Apr;43(4):500-9
9527570 - J Ultrasound Med. 1998 Feb;17(2):109-15
10580971 - Radiology. 1999 Dec;213(3):889-94
2469964 - Nature. 1989 May 4;339(6219):58-61
8128064 - Radiographics. 1994 Jan;14(1):29-50
6198502 - J Pathol. 1983 Nov;141(3):385-413
7480663 - Radiol Clin North Am. 1995 Nov;33(6):1161-70
10933066 - Neoplasia. 2000 Jan-Apr;2(1-2):26-40
14670175 - Neoplasia. 2003 Sep-Oct;5(5):379-88
Radiology. 2006 May;239(2):613
15799826 - Neoplasia. 2005 Mar;7(3):263-70
3526839 - AJR Am J Roentgenol. 1986 Sep;147(3):479-86
2447604 - Radiology. 1988 Jan;166(1 Pt 1):57-62
12790468 - Appl Opt. 2003 Jun 1;42(16):3170-86
12659436 - Opt Lett. 2003 Mar 1;28(5):337-9
9885614 - Radiology. 1999 Jan;210(1):233-40
11110951 - Radiology. 2000 Dec;217(3):832-40
9530316 - Radiology. 1998 Apr;207(1):191-9
1732925 - Radiol Clin North Am. 1992 Jan;30(1):167-85
1678003 - Int J Radiat Biol. 1991 Jul-Aug;60(1-2):85-100
2684393 - Cancer Res. 1989 Dec 1;49(23):6449-65
18364946 - Appl Opt. 2001 Dec 1;40(34):6367-80
11167342 - Acta Radiol. 2001 Jan;42(1):106-13
16926337 - Radiology. 2006 Sep;240(3):912-3; author reply 913-4
15046168 - Appl Opt. 2004 Mar 10;43(8):1654-62
10706610 - Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2767-72
11152812 - Radiology. 2001 Jan;218(1):261-6
9177241 - Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6468-73
11811833 - IEEE Trans Med Imaging. 2001 Dec;20(12):1334-40
1701519 - N Engl J Med. 1991 Jan 3;324(1):1-8
10606224 - Cancer Res. 1999 Dec 1;59(23):5863-70
3881898 - AJR Am J Roentgenol. 1985 Mar;144(3):623-7
10938789 - J Biomed Opt. 2000 Apr;5(2):237-47
1871302 - Radiology. 1991 Sep;180(3):831-5
References_xml – reference: 11937594 - J Nucl Med. 2002 Apr;43(4):500-9
– reference: 6198502 - J Pathol. 1983 Nov;141(3):385-413
– reference: 10938789 - J Biomed Opt. 2000 Apr;5(2):237-47
– reference: 15046168 - Appl Opt. 2004 Mar 10;43(8):1654-62
– reference: 8128064 - Radiographics. 1994 Jan;14(1):29-50
– reference: 10933066 - Neoplasia. 2000 Jan-Apr;2(1-2):26-40
– reference: 12659436 - Opt Lett. 2003 Mar 1;28(5):337-9
– reference: 7480663 - Radiol Clin North Am. 1995 Nov;33(6):1161-70
– reference: 1871302 - Radiology. 1991 Sep;180(3):831-5
– reference: 14670175 - Neoplasia. 2003 Sep-Oct;5(5):379-88
– reference: 9885614 - Radiology. 1999 Jan;210(1):233-40
– reference: 11110951 - Radiology. 2000 Dec;217(3):832-40
– reference: 11152812 - Radiology. 2001 Jan;218(1):261-6
– reference: - Radiology. 2006 May;239(2):613
– reference: 10580971 - Radiology. 1999 Dec;213(3):889-94
– reference: 1678003 - Int J Radiat Biol. 1991 Jul-Aug;60(1-2):85-100
– reference: 15799826 - Neoplasia. 2005 Mar;7(3):263-70
– reference: 16926337 - Radiology. 2006 Sep;240(3):912-3; author reply 913-4
– reference: 2684393 - Cancer Res. 1989 Dec 1;49(23):6449-65
– reference: 3526839 - AJR Am J Roentgenol. 1986 Sep;147(3):479-86
– reference: 1701519 - N Engl J Med. 1991 Jan 3;324(1):1-8
– reference: 10706610 - Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2767-72
– reference: 11167342 - Acta Radiol. 2001 Jan;42(1):106-13
– reference: 18364946 - Appl Opt. 2001 Dec 1;40(34):6367-80
– reference: 11811833 - IEEE Trans Med Imaging. 2001 Dec;20(12):1334-40
– reference: 10606224 - Cancer Res. 1999 Dec 1;59(23):5863-70
– reference: 2447604 - Radiology. 1988 Jan;166(1 Pt 1):57-62
– reference: 1732925 - Radiol Clin North Am. 1992 Jan;30(1):167-85
– reference: 3881898 - AJR Am J Roentgenol. 1985 Mar;144(3):623-7
– reference: 9177241 - Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6468-73
– reference: 9530316 - Radiology. 1998 Apr;207(1):191-9
– reference: 9527570 - J Ultrasound Med. 1998 Feb;17(2):109-15
– reference: 2469964 - Nature. 1989 May 4;339(6219):58-61
– reference: 12790468 - Appl Opt. 2003 Jun 1;42(16):3170-86
SSID ssj0014587
Score 2.2756782
Snippet To investigate prospectively the feasibility of using optical tomography with ultrasonographic (US) localization to differentiate malignant from benign breast...
SourceID pubmed
SourceType Index Database
StartPage 57
SubjectTerms Adult
Aged
Aged, 80 and over
Breast Diseases - diagnosis
Breast Diseases - diagnostic imaging
Breast Neoplasms - diagnosis
Breast Neoplasms - diagnostic imaging
Diagnosis, Differential
Feasibility Studies
Female
Hemoglobins - analysis
Humans
Middle Aged
Predictive Value of Tests
Prospective Studies
Sensitivity and Specificity
Tomography, Optical - methods
Ultrasonography, Doppler, Color
Title Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction
URI https://www.ncbi.nlm.nih.gov/pubmed/16183924
Volume 237
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT9swFLfKkKZdEGNsbDDkw25Vujaxk3S3gUAVEkis7VTtUvkrEIl2FUsuO-4v33t5bvoFGuwSVXYaxX4_O-_Lv8fYJwsLSBphYKVJFYhQxIGGz16gwWCWWVdFpoqYXl7FvaG4GMlRo_FnKWupLHTL_H7wXMn_SBXaQK54SvYZkq0fCg3wG-QLV5AwXJ8k4xM3xbKamFlR_mpOQKW-wbyWpsZM8wIaMKJbEUXMCh-OoXIoBQmEvLDDfnBT5hY0z_lt-YRqF1XWcs0wu6zHflM2X3HI_7gtUVrX5fxTiHEN5N0l_05VGnpR4RlZoXJfRxtruSw8qt9zcrH2sHhQf8UnIevstnqfjaIgFX4z9PtsSOwuK4CiXZMoqjc3c4EHFO6rAbXg3x3kBiO6lCXhziaVdJH4H3Q98e_eNX7tedcW2wJLA0unor_Hx6GETIl11Y_Hx8XhzT5vvBfyz_pnrdkola4y2GU73sjgXwkxr1nDTffYy0ufRvGG3RFwOAGH18DhBBxOwPnCPR74Gmw4wobXsKlv87Dhq7DZZ8Pzs8FpL_BlNwIDwy0CEbskMqZjQXUMjdNdJa2UiW5rqR2YE7ZjU6MyUGQimbg4NF0FWrPSQiinRWLCt-zF9OfUHTCuEtjh29rGFrTAjk1UBta5yOK061KYKPeevaN5Gs-IW2U8n8EPj_YcslcLyB2x7QwWs_sImmGhjyvh_QUPgmTv
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Benign+versus+malignant+breast+masses%3A+optical+differentiation+with+US-guided+optical+imaging+reconstruction&rft.jtitle=Radiology&rft.au=Zhu%2C+Quing&rft.au=Cronin%2C+Edward+B&rft.au=Currier%2C+Allen+A&rft.au=Vine%2C+Hugh+S&rft.date=2005-10-01&rft.issn=0033-8419&rft.volume=237&rft.issue=1&rft.spage=57&rft_id=info:doi/10.1148%2Fradiol.2371041236&rft_id=info%3Apmid%2F16183924&rft_id=info%3Apmid%2F16183924&rft.externalDocID=16183924
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-8419&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-8419&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-8419&client=summon